 |
 Video: What is a Stock Split?
|
|
|
| SWK Holdings focuses on pharmaceutical development, manufacturing and intellectual property licensing business. Co.'s operations comprise two reportable segments: Finance Receivables, which provides customized financing solutions to a range of life science companies, institutions and inventors, and focuses on commercial-stage products and related intellectual property through royalty purchases and financings, as well as through commercialized products; and Pharmaceutical Development, in which through its subsidiary, Enteris BioPharma, Inc., provides formulation solutions built around its proprietary oral drug delivery technologies, the Peptelligence® platform. According to our Swk Holdings stock split history records, Swk Holdings has had 0 splits. | |
|
Swk Holdings (SWKH) has 0 splits in our Swk Holdings stock split history database.
Looking at the Swk Holdings stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Swk Holdings shares, starting with a $10,000 purchase of SWKH, presented on a split-history-adjusted basis factoring in the complete Swk Holdings stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/30/2014 |
|
| End date: |
04/26/2024 |
|
| Start price/share: |
$1.08 |
|
| End price/share: |
$17.35 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
1,506.48% |
|
| Average Annual Total Return: |
32.01% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$160,597.17 |
|
| Years: |
10.00 |
|
|
|
|
|
